Grifols, S.A

(NASDAQ:GRFS)

Latest On Grifols, S.A (GRFS):

Date/Time Type Description Signal Details
2023-05-13 23:16 ESTNewsGrifols: Upside After A Smashing Q1 2023 - I Say 'Buy'N/A
2023-05-10 09:51 ESTNewsGrifols, S.A. (GRFS) Q1 2023 Earnings Call TranscriptN/A
2023-05-10 09:51 ESTNewsGrifols, S.A. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-09 21:01 ESTNewsGrifols S.A. reports Q1 results; raises FY23 guidanceN/A
2023-05-08 18:06 ESTNewsGrifols names new CEO ending founding family’s leadershipN/A
2023-05-08 18:06 ESTNewsGrifols S.A. Q1 2023 Earnings PreviewN/A
2023-03-06 22:10 ESTNewsGrifols, Selagine team up to develop immunoglobulin eye dropsN/A
2023-03-03 14:59 ESTNewsGrifols downgraded at Morgan Stanley citing slower margin recoveryN/A
2023-03-01 04:10 ESTNewsGrifols, S.A. (GRFS) Q4 2022 Earnings Call TranscriptN/A
2023-03-01 04:10 ESTNewsGrifols, S.A. 2022 Q4 - Results - Earnings Call PresentationN/A
2023-02-27 22:34 ESTNewsGrifols S.A. FY 2022 Earnings PreviewN/A
2023-02-23 08:51 ESTNewsGrifols: A Favorite For Some, Speculative Buy For MeN/A
2023-02-15 18:35 ESTNewsGrifols cuts 8% staff mainly in U.S. as cost savings plan takes effectN/A
2022-12-07 04:30 ESTNewsGrifols upgraded to Overweight at Morgan StanleyN/A
2022-11-18 23:56 ESTNewsGrifols Needs To DeleverageN/A
2022-11-11 02:38 ESTNewsGrifols S.A. reports Q3 resultsN/A
2022-09-08 04:06 ESTNewsGrifols inks 15-year deal with Canada for plasma-derived therapiesN/A
2022-07-29 21:31 ESTNewsGrifols: Every Cloud Has A Silver LiningN/A
2022-05-10 18:31 ESTNewsGrifols: Long OnlyN/A
2022-05-09 20:47 ESTNewsGrifols stock slumps on Spain's stock exchange paring gains seen after Q1 resultsN/A
2022-03-31 03:27 ESTNewsGrifols jumps on report on takeover speculation (update)N/A
2022-03-15 13:03 ESTNewsGrifols ABvac40 vaccine for Alzheimer's shows safety/response in phase 2 interim dataN/A
2022-02-25 00:55 ESTNewsGrifols, Endpoint Health team up to develop Antithrombin III for SepsisN/A
2022-02-10 19:31 ESTNewsGrifols: Short-Term Turbulence But Long-Term UpsideN/A
2022-02-07 14:28 ESTNewsGrifols extends losses as JPMorgan points to downside risk to consensusN/A
2021-12-28 18:43 ESTNewsFDA updates EUA for COVID convalescent plasma limiting use to certain patientsN/A
2021-09-22 13:48 ESTNewsGrifols consolidates footprint in blood plasma with agreement to acquire BiotestN/A
2021-07-22 12:25 ESTNewsGrifols launches hepatitis B treatment HyperHEP BN/A
2021-07-22 12:25 ESTNewsGrifols sees revenue contribution from new product launches to ramp by 2030N/A
2021-07-22 12:25 ESTNewsGrifols presents at 2021 investor and analyst day - slideshowN/A
2021-07-22 12:16 ESTNewsGrifols: Valuation Discount Remains Wide Despite An Upbeat Capital Markets DayN/A
2021-06-03 06:11 ESTDividendA dividend of $0.46 has been announced on Nov 30, -0001. It will be paid Jun 14, 2021 with an ex-dividend date of Jun 3, 2021.Neutral
2021-04-29 02:40 ESTNewsGrifols shares rise after Andorra Development and Investment dealN/A
2021-04-21 10:06 ESTNewsGrifols: The Plasma-Supply Disruption Provides An Attractive Entry PointN/A
2021-03-18 23:26 ESTAnalyst RatingThe Analyst Target Price has increased from $27.19 to $27.38.Buy
2021-03-17 22:30 ESTEarnings EstimateAn EPS average of $1.56 is estimated for the 2022 year.Buy
2021-03-17 22:30 ESTEarnings EstimateAn EPS average of $0.38 is estimated for the quarter ending on June 30, 2021.Buy
2021-03-17 22:30 ESTAnalyst RatingThe Analyst Target Price has decreased from $27.31 to $27.19.Neutral
2021-03-16 22:48 ESTAnalyst RatingThe Analyst Target Price has decreased from $32.41 to $27.31.Neutral
2021-03-13 21:13 ESTAnalyst RatingThe Analyst Target Price has decreased from $32.49 to $32.41.Neutral
2021-03-13 05:02 ESTAnalyst RatingThe Analyst Target Price has increased from $32.34 to $32.49.Buy
2021-03-12 13:01 ESTAnalyst RatingThe Analyst Target Price has increased from $31.97 to $32.34.Buy
2021-03-12 05:18 ESTAnalyst RatingThe Analyst Target Price has increased from $31.9 to $31.97.Buy
2021-03-11 01:24 ESTAnalyst RatingThe Analyst Target Price has increased from $31.77 to $31.9.Buy
2021-03-10 05:30 ESTAnalyst RatingThe Analyst Target Price has decreased from $31.97 to $31.77.Neutral
2021-03-09 01:14 ESTAnalyst RatingThe Analyst Target Price has increased from $31.93 to $31.97.Buy
2021-03-07 09:09 ESTAnalyst RatingThe Analyst Target Price has decreased from $32.08 to $31.93.Neutral
2021-03-05 21:26 ESTAnalyst RatingThe Analyst Target Price has decreased from $32.27 to $32.08.Neutral
2021-03-05 12:54 ESTAnalyst RatingThe Analyst Target Price has decreased from $32.36 to $32.27.Neutral
2021-03-04 01:27 ESTAnalyst RatingThe Analyst Target Price has increased from $32.26 to $32.36.Buy

About Grifols, S.A (GRFS):

Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others segments. The Bioscience segment produces plasma-derived medicines for the treatment of rare, chronic, and life-threatening conditions. It offers intravenous immunoglobin, albumin, alpha-1-antitrypsin, factor VIII, antithrombin, and other specialty hyperimmune immunoglobulins. The Hospital segment offers non-biological pharmaceutical products and medical supplies for hospital pharmacy, such as intravenous solutions, pharmatech solutions, clinical nutrition products, and medical devices for interventional therapy. The Diagnostic segment manufactures and markets diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment provides biological products for non-therapeutic uses. The Others segment renders manufacturing services to third party companies. The company also provides engineering services; and rents industrial buildings. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves public and private customers; and wholesalers, distributors, group purchasing organizations, blood banks, hospitals and care institutions, and national health systems. Grifols, S.A. has a technology collaboration agreement with Mondragon. The company was founded in 1940 and is headquartered in Barcelona, Spain.

GRFS Quotes by TradingView

See Advanced Chart

General

  • Name Grifols, S.A
  • Symbol GRFS
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-General
  • Full Time Employees 23,655
  • Last Split Factor2:1
  • Last Split Date2016-01-04
  • Fiscal Year EndDecember
  • IPO Date2006-05-17
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.grifols.com
View More

Valuation

  • Trailing PE 27.04
  • Forward PE 11.99
  • Price/Sales (Trailing 12 Mt.) 1.73
  • Price/Book (Most Recent Quarter) 1.81
  • Enterprise Value Revenue 4.17
  • Enterprise Value EBITDA 15.63
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $1.34
  • Next Year EPS Estimate $1.57
  • Next Quarter EPS Estimate $0.32
  • Profit Margin 12%
  • Return on Assets 5%
  • Return on Equity 10%
  • Earnings Per Share $0.60
  • Revenue Per Share $0
  • Gross Profit 2.51 billion
  • Quarterly Earnings Growth -3.8%
View More

Highlights

  • Market Capitalization 14.95 billion
  • PE Ratio 37.23
  • PEG Ratio 1.78
  • Analyst Target Price $27.38
  • Book Value Per Share $3.56
View More

Share Statistics

  • Shares Outstanding 684.54 million
  • Shares Float 856.69 million
  • % Held by Insiders <1%
  • % Held by Institutions 45.62%
  • Shares Short 3.8 million
  • Shares Short Prior Month 3.72 million
  • Short Ratio 4.17
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta 0.05
  • 52 Week High $21.62
  • 52 Week Low $14.81
  • 50 Day Moving Average 16.54
  • 200 Day Moving Average 17.73
View More

Dividends

  • Forward Annual Dividend Rate $0.42
  • Forward Annual Dividend Yield 2.55%
  • Payout Ratio 16%
  • Dividend Date 2020-11-09
  • ExDividend Date 2020-10-30
  • Dividend Per Share $0.47
  • Dividend Yield 0%
View More

Grifols, S.A (GRFS) Dividend Calendar:

GRFS's last dividend payment was made to shareholders on November 9, 2020.
Grifols, S.A pays out 16% of its earnings out as a dividend.

Ex-Dividend Date Payment Date Record Date Declared Date Amount
2021-06-032021-06-142021-06-040000-00-00$0.46
2020-10-302020-11-092020-11-02$0.2
2019-12-022019-12-112019-12-032019-10-31$0.22
2019-06-072019-06-182019-06-102019-05-29$0.18
2018-11-302018-12-112018-12-032018-11-07$0.23
2018-06-012018-06-122018-06-042018-05-25$0.25
2017-12-012017-12-122017-12-04$0.21
2017-05-302017-06-082017-06-01$0.16
2016-12-052016-12-142016-12-07$0.19
2015-12-102015-12-172015-12-14$0.38
2015-06-082015-06-152015-06-10$0.34
2016-06-020000-00-002016-06-060000-00-00$0.16
2016-06-022016-06-06$0.16

Grifols, S.A (GRFS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-26$1.31 billion$0.29$0.2515.82%
2020-09-302020-11-05$N/A$0.37$0.356.67%
2020-06-302020-07-30$N/A$0.36$0.37-1.33%
2020-03-312020-04-21$1.29 billion$0.24$0.30-18.58%
2019-12-312020-02-27$1.53 billion$0.31$0.31-1.63%
2019-09-302019-10-29$1.43 billion$0.28$0.30-7.05%
2019-06-302019-07-31$1.43 billion$0.33$0.320.12%
2019-03-312019-05-07$1.3 billion$0.25$0.25-1.32%
2018-12-312019-02-28$1.4 billion$0.24$0.31-22.87%
2018-09-302018-11-05$1.32 billion$0.29$0.31-5.83%
2018-06-302018-07-27$1.28 billion$0.34$0.326.69%
2018-03-312018-05-03$1.26 billion$0.28$0.29-3.76%
2017-12-312018-02-28$1.35 billion$0.29$0.31-8.1%
2017-09-302017-11-02$1.34 billion$0.28$0.30-4.31%
2017-06-302017-07-28$1.37 billion$0.28$0.281.53%
2017-03-312017-05-03$1.14 billion$0.27$0.261.71%
2016-12-312017-02-28$956.29 million$0.25$0.253.59%
2016-09-302016-11-08$1.16 billion$0.28$0.2511.6%
2016-06-302016-07-28$1.06 billion$0.26$0.27-5.56%
2016-03-312016-05-05$1.09 billion$0.23$0.24-4.25%
2015-12-312016-02-29$1.07 billion$0.24$0.27-11.48%
2015-09-302015-11-04$1.09 billion$0.26$0.2218.18%
2015-06-302015-07-30$1.14 billion$0.22$0.23-4.35%
2015-03-312015-05-07$975.7 million$0.25$0.244.17%
2014-12-312015-02-26$981.53 million$0.28$0.280%
2014-09-302014-11-04$873.66 million$0.28$0.30-6.67%
2014-06-302014-07-31$1.11 billion$0.32$0.306.67%
2014-03-312014-05-06$1.1 billion$0.24$0.28-14.29%
2013-12-312014-02-27$1.01 billion$0.16
2013-09-302013-11-05$973.55 million$0.16
2013-06-302013-07-31$920.25 million$0.18
2013-03-312013-05-02$876.23 million$0.18
2012-12-312013-02-28$936.82 million$0.12
2012-09-302012-10-31$851.15 million$0.07$0.13-46.15%
2012-06-302012-07-31$779.05 million$0.08$0.27-70.37%
2012-03-312012-04-24$888.95 million$0.13
2011-12-312012-02-29$708.12 million$0.00
2011-09-302011-11-11$698.63 million$0.05
2011-06-302011-07-28$551.92 million-$0.03

Grifols, S.A (GRFS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Grifols, S.A (GRFS) Chart:

Grifols, S.A (GRFS) News:

Below you will find a list of latest news for Grifols, S.A (GRFS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Grifols, S.A (GRFS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-12-1920CALL0 0523.55TRUE00
2025-12-1936.6CALL0 10386.98TRUE00
2025-12-1940CALL0 0293.46TRUE00
2025-12-1954.88CALL0 10245.43TRUE00
2025-12-1964CALL0 6181.33TRUE00
2025-12-1973.06CALL0 49118.15TRUE00
2025-12-1981.7CALL0 4467.58TRUE00
2025-12-1990.05CALL0 12455.62FALSE00
2025-12-19100.05CALL0 32853.12FALSE00
2025-12-19110.1CALL0 136256.04FALSE00
2025-12-19120.01CALL0 804250.57FALSE00
2025-12-19130CALL0 0320.04FALSE00
2025-12-19140CALL0 0345.98FALSE00
2025-12-19150.05CALL0 145156.8FALSE00
2025-12-19160CALL0 0389.98FALSE00
2025-12-19170CALL0 0408.98FALSE00
2025-12-19180CALL0 0426.42FALSE00
2025-12-1920PUT0 0997.12FALSE00
2025-12-1930PUT0 0724.28FALSE00
2025-12-1940PUT0 0556.86FALSE00
2025-12-1950.04PUT0 420217.01FALSE00
2025-12-1960PUT0 4265.44FALSE00
2025-12-1970.1PUT0 148254.27FALSE00
2025-12-1980.15PUT0 8178.01FALSE00
2025-12-1991.05PUT0 9454.6TRUE00
2025-12-19101.47PUT0 124112.09TRUE00
2025-12-19111.2PUT0 0175.51TRUE00
2025-12-19120PUT0 0189.24TRUE00
2025-12-19130PUT0 0215.96TRUE00
2025-12-19140PUT0 0239.47TRUE00
2025-12-19150PUT0 00TRUE00
2025-12-19160PUT0 00TRUE00
2025-12-19170PUT0 00TRUE00
2025-12-19180PUT0 00TRUE00
2026-01-1610CALL0 0457.68TRUE00
2026-01-1620CALL0 0306.06TRUE00
2026-01-1630CALL0 0225.87TRUE00
2026-01-1640CALL0 0187.39TRUE00
2026-01-1650CALL0 0142.18TRUE00
2026-01-1660CALL0 00TRUE00
2026-01-1670CALL0 0123.33TRUE00
2026-01-1680CALL0 0191.6TRUE00
2026-01-1690.15CALL0 461.69FALSE00
2026-01-16100CALL0 0176.86FALSE00
2026-01-16110.15CALL0 4187.73FALSE00
2026-01-16120CALL0 0203.26FALSE00
2026-01-16130CALL0 0180.89FALSE00
2026-01-16140CALL0 0195.49FALSE00
2026-01-16150CALL0 0208.51FALSE00
2026-01-16160CALL0 0220.26FALSE00
2026-01-16170CALL0 0230.96FALSE00
2026-01-1610PUT0 0991.98FALSE00
2026-01-1620PUT0 0562FALSE00
2026-01-1630PUT0 0408.09FALSE00
2026-01-1640PUT0 0313.68FALSE00
2026-01-1650PUT0 0244.98FALSE00
2026-01-1660PUT0 0190.05FALSE00
2026-01-1670PUT0 0143.04FALSE00
2026-01-1680PUT0 0100FALSE00
2026-01-1690PUT0 0150.11TRUE00
2026-01-16100PUT0 0154.25TRUE00
2026-01-16110PUT0 0199.44TRUE00
2026-01-16120PUT0 0116.81TRUE00
2026-01-16130PUT0 0132.51TRUE00
2026-01-16140PUT0 0146.35TRUE00
2026-01-16150PUT0 00TRUE00
2026-01-16160PUT0 00TRUE00
2026-01-16170PUT0 00TRUE00
2026-02-2010CALL0 0350.17TRUE00
2026-02-2020CALL0 0233.48TRUE00
2026-02-2030CALL0 0172.11TRUE00
2026-02-2040CALL0 0141.91TRUE00
2026-02-2055.01CALL0 4107.63TRUE00
2026-02-2060CALL0 00TRUE00
2026-02-2071.85CALL0 576.95TRUE00
2026-02-2081.6CALL25 476.01TRUE1.60
2026-02-2091CALL25 7567.93FALSE10
2026-02-20100.2CALL0 13440.33FALSE00
2026-02-20110.44CALL0 3890.8FALSE00
2026-02-20120.03CALL0 54104.63FALSE00
2026-02-20130.16CALL0 1116.5FALSE00
2026-02-20140CALL0 0126.91FALSE00
2026-02-20150.1CALL0 1275.01FALSE00
2026-02-20160CALL0 0144.58FALSE00
2026-02-20170CALL0 0152.21FALSE00
2026-02-2010PUT0 0730.51FALSE00
2026-02-2020PUT0 0413.25FALSE00
2026-02-2030PUT0 0299.96FALSE00
2026-02-2040PUT0 0230.49FALSE00
2026-02-2050PUT0 0179.95FALSE00
2026-02-2060PUT0 0139.53FALSE00
2026-02-2070.5PUT0 1117.03FALSE00
2026-02-2080.4PUT0 3873.22FALSE00
2026-02-2090.85PUT0 17149.13TRUE00
2026-02-20101.2PUT0 434.05TRUE00
2026-02-20110PUT0 0159.23TRUE00
2026-02-20120PUT0 00TRUE00
2026-02-20130PUT0 0108.63TRUE00
2026-02-20140PUT0 0119.28TRUE00
2026-02-20150PUT0 0121.08TRUE00
2026-02-20160PUT0 0129.6TRUE00
2026-02-20170PUT0 0137.41TRUE00
2026-05-1520CALL0 0172.86TRUE00
2026-05-1536.7CALL0 10137.04TRUE00
2026-05-1540CALL0 0104.04TRUE00
2026-05-1554.5CALL0 80TRUE00
2026-05-1563.6CALL0 267.12TRUE00
2026-05-1570CALL0 0196.38TRUE00
2026-05-1581.64CALL0 15174.09TRUE00
2026-05-1591.1CALL0 80843.71FALSE00
2026-05-15100.63CALL1 14146.7FALSE-0.02-0.03
2026-05-15110.3CALL0 11154.57FALSE00
2026-05-15121CALL0 173.1FALSE00
2026-05-15130.1CALL0 1081.26FALSE00
2026-05-15140CALL0 088.43FALSE00
2026-05-15150CALL0 0169.46FALSE00
2026-05-15160CALL0 0100.59FALSE00
2026-05-15170CALL0 0105.85FALSE00
2026-05-15180CALL0 0110.68FALSE00
2026-05-1520PUT0 0285.45FALSE00
2026-05-1530PUT0 0206.99FALSE00
2026-05-1540PUT0 0158.91FALSE00
2026-05-1550PUT0 0103.32FALSE00
2026-05-1560PUT0 095.95FALSE00
2026-05-1570PUT0 0181.59FALSE00
2026-05-1580.87PUT0 4161.49FALSE00
2026-05-1591.1PUT0 1185.71TRUE00
2026-05-15101.7PUT0 358.04TRUE00
2026-05-15110PUT0 038.2TRUE00
2026-05-15120PUT0 040.45TRUE00
2026-05-15130PUT0 038.83TRUE00
2026-05-15140PUT0 092.4TRUE00
2026-05-15150PUT0 099.39TRUE00
2026-05-15160PUT0 0105.75TRUE00
2026-05-15170PUT0 092.65TRUE00
2026-05-15180PUT0 00TRUE00

Latest GRFS Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST24$11.835
Jun 13, 2022 7:59 PM EST80$11.835
Jun 13, 2022 7:59 PM EST80$11.835
Jun 13, 2022 7:59 PM EST142$11.835
Jun 13, 2022 7:59 PM EST10$11.83

Grifols, S.A (GRFS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920070749/0001104659-20-070749-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1438569/000031506619001082/0000315066-19-001082-index.htm
2019-07-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1438569/000031506619001598/0000315066-19-001598-index.htm
2018-05-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918030037/0001104659-18-030037-index.htm
2018-05-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918031927/0001104659-18-031927-index.htm
2018-05-256-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918035864/0001104659-18-035864-index.htm
2018-06-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918037898/0001104659-18-037898-index.htm
2018-06-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918038773/0001104659-18-038773-index.htm
2018-06-19SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1438569/000110465918040970/0001104659-18-040970-index.htm
2018-07-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918047551/0001104659-18-047551-index.htm
2018-08-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918048670/0001104659-18-048670-index.htm
2018-09-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918055714/0001104659-18-055714-index.htm
2018-10-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918060259/0001104659-18-060259-index.htm
2018-10-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918064237/0001104659-18-064237-index.htm
2018-11-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918065575/0001104659-18-065575-index.htm
2018-11-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918065887/0001104659-18-065887-index.htm
2018-11-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918069526/0001104659-18-069526-index.htm
2018-11-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918069680/0001104659-18-069680-index.htm
2018-12-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918073562/0001104659-18-073562-index.htm
2018-12-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465918075244/0001104659-18-075244-index.htm
2019-02-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919011270/0001104659-19-011270-index.htm
2019-03-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919013238/0001104659-19-013238-index.htm
2019-03-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919018669/0001104659-19-018669-index.htm
2019-04-0520-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1438569/000110465919020063/0001104659-19-020063-index.htm
2019-04-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919021489/0001104659-19-021489-index.htm
2019-04-2320-F/AAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1438569/000110465919023085/0001104659-19-023085-index.htm
2019-05-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919026164/0001104659-19-026164-index.htm
2019-05-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919027308/0001104659-19-027308-index.htm
2019-05-246-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919031663/0001104659-19-031663-index.htm
2019-06-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919033920/0001104659-19-033920-index.htm
2019-07-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919039379/0001104659-19-039379-index.htm
2019-07-166-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919040426/0001104659-19-040426-index.htm
2019-07-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919042789/0001104659-19-042789-index.htm
2019-10-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919056835/0001104659-19-056835-index.htm
2019-10-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919057088/0001104659-19-057088-index.htm
2019-10-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919058031/0001104659-19-058031-index.htm
2019-11-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919062979/0001104659-19-062979-index.htm
2019-11-156-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919064554/0001104659-19-064554-index.htm
2019-11-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919065722/0001104659-19-065722-index.htm
2019-12-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919070538/0001104659-19-070538-index.htm
2019-12-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465919070539/0001104659-19-070539-index.htm
2020-02-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920022273/0001104659-20-022273-index.htm
2020-02-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920026130/0001104659-20-026130-index.htm
2020-03-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920038405/0001104659-20-038405-index.htm
2020-03-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920039290/0001104659-20-039290-index.htm
2020-04-0620-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1438569/000110465920043470/0001104659-20-043470-index.htm
2020-04-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920049070/0001104659-20-049070-index.htm
2020-05-076-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920057912/0001104659-20-057912-index.htm
2020-06-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920070749/0001104659-20-070749-index.htm
2020-07-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920084649/0001104659-20-084649-index.htm
2020-07-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920088132/0001104659-20-088132-index.htm
2020-09-046-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920102386/0001104659-20-102386-index.htm
2020-09-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920102797/0001104659-20-102797-index.htm
2020-10-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920110940/0001104659-20-110940-index.htm
2020-10-096-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920113682/0001104659-20-113682-index.htm
2020-10-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920116641/0001104659-20-116641-index.htm
2020-11-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1438569/000110465920121561/0001104659-20-121561-index.htm